Needham & Co. Raises PT on Cantel Medical (CMN) to $33

December 7, 2012 9:14 AM EST
Get Alerts CMN Hot Sheet
Price: $81.14 +0.77%

Rating Summary:
    3 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 18 | New: 11
Trade CMN Now!
Join SI Premium – FREE
Following the company's positive earnings report yesterday, Needham & Company maintained a Buy rating on Cantel Medical (NYSE: CMN) and raised its price target to $33.00 (from $28.00).

Commenting on the results, analyst Dalton Chandler said, "CMN slightly missed our revenue estimate, but emphasis on new, higher margin products and focus on cost controls helped the company easily top our bottom line estimate. These improvements appear to be sustainable and could improve further."

For an analyst ratings summary and ratings history on Cantel Medical (NYSE: CMN) click here. For more ratings news on Cantel Medical click here.

Shares of Cantel Medical closed at $28.51 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Needham & Company, Earnings

Add Your Comment